서울바이오시스

092190KOSDAQ반도체 제조업

52.3 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40

News Sentiment21.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 20.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Seoul Biosys provides comprehensive solutions ranging from UV to IR, laser diodes, and VCSELs through six global R&D centers and production infrastructure, with over 7,000 patents protecting its 200nm–1600nm wavelength optical semiconductor technology. The company leads in key markets such as automotive lighting and UV LED, where it holds the top market share, and is projected to grow at a 12% annual rate across six major industries including micro LED and VCSEL.

Number of Employees

193people

Average Salary

60.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 33.104.0Point

PBR

2.60Industry Average 2.132.5Point

Higher than industry avg (caution)

ROE

-8.97Industry Average -3.923.5Point

2.3x industry avg (excellent)

Debt Ratio

38.40Industry Average 14.750.0Point

2.6x industry avg (risky)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲24.0% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲5.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -23.7% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
서울반도체, 1분기 흑자전환
서울반도체가 1분기 흑자전환을 달성하며 매출 소폭 감소에도 불구하고 실적 개선을 보여주었다.
Positive
서울바이오시스, 1분기 영업익 108억…전년비 흑자전환
서울바이오시스의 분기별 매출과 영업이익이 증가하며 흑자 전환을 달성, 긍정적인 재무 성과 발표.

Detailed Momentum

52-week position5.0Point

52w mid range (48%)

Current 9,630Won52-week high 17,57052-week low 2,185

1-month return0.0Point

1m -20.48% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral분기보고서 (2026.03)2026-05-15